Dr. May Griffith
Founder and Board of Director
Biopharma
Ferentis Pharma
Lithuania
Biography
Dr. May Griffith is the key founder and a leading global expert in the field of regenerative medicine, with special interests in biomaterials enhanced or enabled cell-based regeneration. She is Professor of Regenerative Medicine and Director of the Integrative Regenerative Medicine Centre (IGEN) at LinkÅ‘ping University, Sweden, and an Adjunct Professor at the University of Ottawa, Canada. Dr. Griffith obtained her PhD from the University of Toronto, and completed her postdoctoral fellowship at Harvard Medical School, Boston. She also has an Executive MBA from the University of Ottawa. Dr. Griffith has collaborated on research projects with instutions from all over the world, as well as worked on collaborative research with companies as CooperVision, Unilever, Procter & Gamble, Santen Paharmaceutical, etc. She received numerous awards, including International Association of Advanced Materials Nanomedical Technology Medal of the Year (2011), and Ottawa‘s Centre for Research and Innovation Life Sciences Research Award (2007). She is a member of the Canadian Stem Cell Network. Dr. Griffith has published over 90 papers in refereed scientific journals, reviews, book chapters, has issued patents and has licensed products for commercial application. Dr. Griffith was coordinator of the EU Nanomedicine project "I-CARE" from which UAB Ferentis is a spin-off.
Research Interest
Medicine, Regenarative Medicine, Genetics
